Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

JF06-EMR-Medical-Information-Technology-Systems
Disease Drug Company Therapeutic Role Type of Drug Diagnostic Test Specified Approval Type Medicare Payment Category Margenza (margetuximab- cmkb ) Macrogenics Third-line for metastatic, HER2+ disease HER2-neu receptor antagonist None Full Part B Phesgo (pertuzumab, trastuzumab, hyaluronidase- zzxf ) Genentech Neoadjuvant for HER2+ early BC, adjuvant for high risk …
Use this list of recommended websites to bookmark to help you start building a database of easily accessible resources.
VAHO 23 9.7-9.8 Attendee Roster - 9.1.xlsx VAHO Leadership Day September 7-8th, 2023 Delta Richmond Richmond, VA Attendee Roster First Name Last Name Title Account Name Sarah Lanford State Advocacy Specialist American Society of Clinical Oncology (ASCO) Allen Miles Oncology Portfolio Manager Amgen Oncology Joseph LaCognata Territory Business Manager, Mid Atlantic …
TxSCO 9.23 Attendee Roster as of 9.14.xlsx TxSCO 2023 Annual Conference September 23, 2023 Hyatt Regency Frisco Dallas Frisco, TX Attendee Roster First Name Last Name Title Account Name Ashley Barlow PharmD AbbVie Inc. Jigar Trivedi Medical Science Liaison (Hematology) AbbVie Inc. Kristin Evans Account Executive AbbVie Inc. Mary Peterson Nurse Practitioner/Oncology Clinical …
KaSCO 2023 Attendee Roster Updated 10.27.xlsx KaSCO 2023 Annual Conference October 28th, 2023 Hyatt Regency Wichita Wichita, KS Attendee Roster First Name Last Name Title Account Name Raid Abu-Awwad MD Ascension Via Christi St. Francis Abdel-GhanieAbu-Samra MD Ascension Via Christi St. Francis Christopher Halphen Orthopedic Oncology Ascension Via Christi St. Francis Keisha …
Pathologic Differences in Patients with Breast Cancer at BMC Project Background, Hypothesis and Design What’s Happening in Breast Cancer Michelle Loch, MD LSU Health Sciences Center April 19, 2024 Objectives • Review advances in breast cancer in 2023 • Early breast cancer • Survivorship • Metastatic Breast Cancer • On the horizon Early Breast Cancer …
CAR T-cell Therapy for Diffuse Large B-Cell Lymphoma Paolo Strati, MD Department of Lymphoma and Myeloma Department of Translational Molecular Pathology The University of Texas MD Anderson Cancer Center Texas Society of Clinical Oncology 2022 Disclosure of Conflicts of Interest Paolo Strati, MD, has the following financial relationships to disclose: • Consultant …
White title slide Molecular Tumor Board Mark E. Burkard MD PhD Mary and Rob Gooze Chair in Metastatic Breast Cancer University of Wisconsin- Madison Disclosures M.E.B. declares the following: • Strata Oncology (Medical Advisory Board) • Abbvie, Arcus, Apollomics, Elevation Oncology, Genentech, Puma, Loxo Oncology, Seagen (Research funding) • Novartis, Strata Oncology …
White title slide Molecular Tumor Board Mark E. Burkard MD PhD Mary and Rob Gooze Chair in Metastatic Breast Cancer University of Wisconsin- Madison Disclosures M.E.B. declares the following: • Strata Oncology (Medical Advisory Board) • Abbvie, Arcus, Apollomics, Elevation Oncology, Genentech, Puma, Loxo Oncology, Seagen (Research funding) • Novartis, Strata Oncology …
Tacos 11.10 Attendee Roster - 11.2.xlsx TACOS 2023 Fall Conference November 10-11th, 2023 DoubleTree Resort by Hilton Hotel Paradise Valley - Scottsdale Scottsdale, AZ Attendee Roster First Name Last Name Title Account Name Scott Tabot Area Business Manager Agios Gordon Warlaumont Clinical Educator Agios Ruth Walker-Simelton Practice Manager Alliance Cancer Care Arizona Brian …
PowerPoint Presentation ©2018 MFMER | slide-1 Biliary Tract Cancers: Paradigm for Advancement of Systemic Therapy in a Rare Disease Amit Mahipal MBBS, MPH Professor Department of Oncology Mayo Clinic, Rochester 4/21/22 ©2018 MFMER | slide-2 Disclosure of Conflicts of Interests Amit Mahipal MBBS, MPH has the following financial relationships to disclose: • Advisory …
Volunteer Succession & Leadership Transition Planning 03142024 Succession Planning for your Whole Practice Elisa Pratt, MA, CAE, CVF CEO & Chief Strategist Brewer Pratt Solutions, LLC We lc o m e ! Elisa Pratt, MA, CAE, CVF is a leadership guru and expert in strategic nonprofit solutions that increase membership, diversify revenue and ensure relevance. Prior to the founding …
ASCO 2024 Hematologic malignancy ASCO 2024 Hematologic malignancy SUZANNE FANNING, DO PRISMA HEALTH CANCER INSTITUTE Outline Myeloid malignancies a. CML b. AML NHL a. Mantle cell b. Follicular Multiple myeloma a. NDMM b. RRMM ASC4FIRST, a pivotal phase 3 study of asciminib (ASC) vs investigator-selected tyrosine kinase inhibitors (IS …
Exercise and Diet in Cancer Patients: Current Guidelines Carolyn M. Matthews, MD October 2022 Disclosure of Conflicts of Interest Carolyn M. Matthews, MD, has no relevant financial relationships to disclose. Role of Nutrition in Oncology Community interest Oncologist Research Prevention/treatment/survivorship Overweight/obesity Cancer causation …
WAHO WON 23 9.16 Attendee Roster - 9.7.xlsx WAHO/WON 2023 Annual Conference September 16, 2023 Hyatt Regency Green Bay/KI Convention Center Green Bay, WI Attendee Roster First Name Last Name Title Account Name Chris Denzler Senior Manager AbbVie Inc. Justin Hayne Senior Medical Science Liaison AbbVie Inc. Erik Hyde Hematology Account Executive AbbVie Inc. Kate Retz Medical …
Abstract - MSCO Spring Conference 2022 RESEARCH POSTER PRESENTATION DESIGN © 2015 www .PosterP resen tations .com • Non-small cell lung cancer(NSCLC) has propensity to metastasize to bones – around 40%. • Bone Marrow involvement very rare, unlike in SCLC • Persistent cytopenias as a result of diffuse bone marrow infiltration is uncommon • Bone Marrow biopsy is not …
Lung Cancer Maggie Byrne, MD, MS Clinical Assistant Professor Holden Comprehensive Cancer Center, University of Iowa Maggie Byrne, MD, MS has no relevant financial relationships to disclose. Disclosure of Conflicts of Interest Metastatic NSCLC without targetable genomic alterations 1st line Abstract 9000, Pooled analysis of 12 randomized studies comparing IO vs …
NOS 2023 SPRING CONFERENCE MAY 13, 2023 Las Vegas, NV Attendee List Name Title Organization Sierra Velasquez, ANP-BC MSL AbbVie Inc. Gregg Anderson DHS Adaptive Biotechnologies Brenda Stack Agios Shimere Sherwood Associate Director American Society of Clinical Oncology (ASCO) Sheryl McDonald Senior Oncology Specialist Amgen Oncology Freddie Carney Sr Oncology …
IOS-IA 2024 Spring Conference Friday March 8th, 2024 Marriot Des Moins Downtown Hotel Des Moins IA Attendee Roster First Name Last Name Title Account Name Javier Leaniz AbbVie Inc. Daphne Hao Management Development Program AbbVie Inc. Justin Hayne Senior Medical Science Liaison AbbVie Inc. Scott Vance Hematology Account Executive AbbVie Inc. Anthony Belott Chief Development …